Literature DB >> 8318675

Cytokine down-regulation in endotoxin tolerance.

M Mengozzi1, P Ghezzi.   

Abstract

Cytokine production is down-regulated in LPS tolerance. 1) This down-regulation has been reported in various animal species and cell types, and can be induced both in vivo and in vitro (indicating a desensitization of the cytokine-producing cells). 2) It can also be induced in humans in vivo and in vitro. 3) It is reversible, since the refractory state can be bypassed by administering LPS along with IFN-gamma or PMA. 4) Under certain conditions, it is specific since cytokines will still be induced in response to non-LPS stimuli (Staphylococcus, zymosan, MDP), meaning a real LPS-desensitization is involved rather than an aspecific blockade of cytokine synthesis. 5) in vivo, due to the complexity of the system, other factors than a simple desensitization of cytokine-producing cells contribute to LPS tolerance (aspecific blockade of cytokine synthesis, corticosteroid-dependent feedback, increased clearance by RES and changes in macrophage populations, inhibitory cytokines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318675

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  19 in total

1.  Autoregulatory effect of interleukin-10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes.

Authors:  H Shimauchi; T Ogawa; K Okuda; Y Kusumoto; H Okada
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Metabolic changes detected by microdialysis during endotoxin shock and after endotoxin preconditioning.

Authors:  S Klaus; M Heringlake; K Block; J Nolde; K Staubach; L Bahlmann
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

3.  Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells.

Authors:  Jihoon Chang; Steven L Kunkel; Cheong-Hee Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

4.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

5.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

Authors:  D J Berg; R Kühn; K Rajewsky; W Müller; S Menon; N Davidson; G Grünig; D Rennick
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Role of CD 11/CD 18 in neutrophil emigration during acute and recurrent Pseudomonas aeruginosa-induced pneumonia in rabbits.

Authors:  T Kumasaka; N A Doyle; W M Quinlan; L Graham; C M Doerschuk
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.

Authors:  Katherine M Howard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

8.  Transient endotoxemia during burn wound revision causes leukocyte beta 2 integrin up-regulation and cytokine release.

Authors:  O Ljunghusen; S Berg; J Hed; J Lundahl; H Nettelblad; F Sjögren; O Stendahl
Journal:  Inflammation       Date:  1995-08       Impact factor: 4.092

9.  Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-κB suppression.

Authors:  Rahul Checker; Raghavendra S Patwardhan; Deepak Sharma; Jisha Menon; Maikho Thoh; Santosh K Sandur; Krishna B Sainis; T B Poduval
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

10.  Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice.

Authors:  R Faggioni; G Fantuzzi; P Villa; W Buurman; L J van Tits; P Ghezzi
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.